Friday, December 17, 2021
Adalimumab, Processes for Manufacturing or Relating to Same, and Products Containing Same
Mareesa A. Frederick
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
AbbVie Inc., AbbVie Biotechnology Ltd, and AbbVie Operations Singapore Pte. Ltd.
Letter to Lisa R. Barton, Secretary, USITC; requesting that the Commission conduct an investigation under section 337 of the Tariff Act of 1930, as amended, in the matter of certain adalimumab, processes for manufacturing or relating to same, and products containing same. The proposed respondents are Alvotech hf., Iceland; Alvotech Germany GmbH, Germany; Alvotech Swiss AG, Switzerland; Alvotech USA Inc., Arlington, VA; Teva Pharmaceutical Industries Ltd., Israel; Teva Pharmaceuticals USA Inc., North Wales, PA; and Ivers-Lee AG, Switzerland.